Shop
eStoreRx™
Online Supplement Dispensary
Easy direct-to-patient ordering & fulfilment for Lifelong Wellness, eStoreRx™ is offered as part of the WholePractice membership or as a stand-alone program.
For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional
This inclusive membership contains all of the the tools you need to grow your business, including WholeLifeRx™, Nimativ®, WholeLifeQ™, eStoreRx™ and Practice Success Programs.
Easy direct-to-patient ordering & fulfilment for Lifelong Wellness, eStoreRx™ is offered as part of the WholePractice membership or as a stand-alone program.
April 18 2024
Results of a large population-based observational cohort study examining the association between weight loss and diabetes remission were recently publ...
Researchers wishing to evaluate the safety profile and characterize the immunologic effects of high dose vs low dose cholecalciferol (vitamin D3) supplementation in patients with MS, conducted a double-blind, randomized study of 40 patients with relapsing-remitting MS. Patients received 10,400 IU or 800 IU of D3 daily for 6 months. Assessments were conducted at baseline, 3 and 6 months. Results showed a mean increase of 25(OH)D levels was greater in the high dose group vs the low dose group. In the high dose group only, they found a reduction in the proportion of interleukin-17+CD4+ T cells, CD161+CD4+ T cells, and effector memory CD4+ T cells with concomitant increase in central memory CD4+ T cells and naïve CD4+ T cells. In other words, as the levels of vitamin D increased, there was a corresponding decrease in the levels of CD4+ T cells and interleukin-17, a protein they create which is pro-inflammatory. The researchers concluded that vitamin D3 supplementation with 10,400 IU daily is safe and tolerable in patients with MS and exhibits in vivo pleiotropic immunomodulatory effects in MS.
Sotirchos ES, et al. Safety and immunologic effects of high-vs low-dose cholecalciferol in multiple sclerosis. Neurology. 2015
Submit this form and you'll receive our latest news and updates.
*These statements have not been evaluated by the Food and Drug Administration. This product has not intended to diagnose, treat, cure, or prevent any disease.
© 2023 Biotics Research Corporation - All Rights Reserved
Submit your comment